Cognitive impairment (CI) is present in all stages and subtypes of multiple sclerosis (MS). However, the majority of studies examined relapsing-remitting (RRMS) patients, and did not address cognitive phenotyping. Is still not clear whether patients with progressive MS (PMS) have a distinct pattern of CI compared to RRMS. In addition, there is conflicting data regarding the correlation between clinical and cognitive disability. To investigate the differences of CI between PMS and RRMS patients, evaluating cognitive phenotypes. We also aimed to analyze the association between physical and cognitive disability with MRI measures of grey-matter atrophy and lesion burden.Thirty patients with PMS and twenty-four with RRMS underwent neurological, ...
This paper presents results of two studies conducted to investigate cognition in different MS subtyp...
BackgroundCognitive impairment is frequent and disabling in multiple sclerosis (MS). Changes in info...
Cognitive disorders occur in up to 65 % of multiple sclerosis (MS) patients; they have been correlat...
Multiple Sclerosis (MS) is a chronic inflammatory/demyelinating and neurodegenerative disease of the...
Multiple Sclerosis (MS) is a chronic inflammatory/demyelinating and neurodegenerative disease of the...
There is limited and inconsistent information on the clinical determinants of cognitive impairment (...
Objective: to investigate the cognitive skills of patients with relapsing remitting multiple scleros...
Objective: To investigate the cognitive skills of patients with relapsing remitting multiple scleros...
Background: Cognitive impairment is a common symptom of multiple sclerosis (MS), but the association...
AIMS: Multiple sclerosis (MS) is a neurologic disease characterized by the occurrence of wideapread ...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Background Cognitive impairment is a common symptom of multiple sclerosis (MS), but the association ...
Patients with multiple sclerosis (MS) commonly exhibit cognitive impairments (CI). However, the neur...
Cognitive impairment may result in significant disability in patients with Multiple Sclerosis (MS). ...
Objectives: To characterize cognitive impairment in primary progressive multiple sclerosis (PPMS) an...
This paper presents results of two studies conducted to investigate cognition in different MS subtyp...
BackgroundCognitive impairment is frequent and disabling in multiple sclerosis (MS). Changes in info...
Cognitive disorders occur in up to 65 % of multiple sclerosis (MS) patients; they have been correlat...
Multiple Sclerosis (MS) is a chronic inflammatory/demyelinating and neurodegenerative disease of the...
Multiple Sclerosis (MS) is a chronic inflammatory/demyelinating and neurodegenerative disease of the...
There is limited and inconsistent information on the clinical determinants of cognitive impairment (...
Objective: to investigate the cognitive skills of patients with relapsing remitting multiple scleros...
Objective: To investigate the cognitive skills of patients with relapsing remitting multiple scleros...
Background: Cognitive impairment is a common symptom of multiple sclerosis (MS), but the association...
AIMS: Multiple sclerosis (MS) is a neurologic disease characterized by the occurrence of wideapread ...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Background Cognitive impairment is a common symptom of multiple sclerosis (MS), but the association ...
Patients with multiple sclerosis (MS) commonly exhibit cognitive impairments (CI). However, the neur...
Cognitive impairment may result in significant disability in patients with Multiple Sclerosis (MS). ...
Objectives: To characterize cognitive impairment in primary progressive multiple sclerosis (PPMS) an...
This paper presents results of two studies conducted to investigate cognition in different MS subtyp...
BackgroundCognitive impairment is frequent and disabling in multiple sclerosis (MS). Changes in info...
Cognitive disorders occur in up to 65 % of multiple sclerosis (MS) patients; they have been correlat...